Cargando…
Breast Cancer Stem Cells Survive Periods of Farnesyl-Transferase Inhibitor-Induced Dormancy by Undergoing Autophagy
A cancer stem cell has been defined as a cell within a tumor that possesses the capacity to self-renew and to cause the heterogeneous lineages of cancer cells that comprise the tumor. These tumor-forming cells could hypothetically originate from stem, progenitor, or differentiated cells. Previously,...
Autores principales: | Chaterjee, Moumita, van Golen, Kenneth L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3199942/ https://www.ncbi.nlm.nih.gov/pubmed/22046561 http://dx.doi.org/10.1155/2011/362938 |
Ejemplares similares
-
Use of Farnesyl Transferase Inhibitors in an Ageing Model in Drosophila
por: Brandt, Annely, et al.
Publicado: (2023) -
Potential of Farnesyl Transferase Inhibitors in Combination Regimens in Squamous Cell Carcinomas
por: Kessler, Linda, et al.
Publicado: (2021) -
Farnesyl transferase inhibitors induce extended remissions in transgenic mice with mature B cell lymphomas
por: Field, Kenneth A, et al.
Publicado: (2008) -
Molecular docking and simulation of Curcumin with Geranylgeranyl Transferase1 (GGTase1) and Farnesyl Transferase (FTase)
por: Subramani, Parasuraman Aiya, et al.
Publicado: (2015) -
Phase I and pharmacokinetic study of irinotecan in combination with R115777, a farnesyl protein transferase inhibitor
por: Sparreboom, A, et al.
Publicado: (2004)